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CORRESPONDENCEComment on: ‘Effects of Statin Therapy on Abdominal
Aortic Aneurysm Growth: A Meta-analysis and Meta-
regression of Observational Comparative Studies’
Dear Editor,
We read the meta-analysis by Takagi et al.1 with interest.
Unfortunately, the conclusion that statins reduce AAA
expansion is still not justiﬁed by the data.
The problem, as with our analysis widely quoted in the
paper,2 is that the study quality was poor with small patient
numbers in individual studies. Study results were open to
confounding from multiple comorbidities and polypharmacy
in AAA patient groups. Heterogeneity in the authors’ anal-
ysis was highly signiﬁcant (adjusted from P < 0.0001 to
P ¼ 0.005), with a signiﬁcant variation between expansion
rate results suggesting bias. Adjusting confounded or biased
data and performing meta-regression simply produce
further inaccurate results without correcting the underlying
problem. Meta-analysis is only as good as the trial data
entered.3
For these reasons we based our conclusion on sensi-
tivity analysis rather than the meta-analysis of all trials
which found in favour of the statin group.2 Adding the
‘high quality’ trial (Karrowni 2011) published since our
analysis pushes our high quality sensitivity analysis result
into signiﬁcance (SMD 0.25, P ¼ 0.04, Heterogeneity
P < 0.0001) but still gave a non signiﬁcant result from
large volume (>200 patients total) sensitivity analysis
(SMD 0.20, P ¼ 0.07, Heterogeneity P ¼ 0.006), high-
lighting how brittle meta-analysis really is when using
small individual datasets.
A more deﬁnitive attempt to answer this question can
only be made by adjusted re-analysis of pooled raw data
from these studies or a high quality RCT.
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Dear Editor,
We would like to greatly acknowledge the comment by
Twine and Williams on our recently published meta-anal-
ysis.1 In a more recent (after our performing the meta-
analysis1) meta-analysis by the RESCAN collaborators2 of
individual data collated from people under follow-up for
a small (3.0e5.4 cm in diameter) abdominal aortic aneurysm
(AAA), the pooled meta-analysis estimate (4621 patients
from 6 studies) was no longer statistically signiﬁcant for
statins/lipid-lowering drugs (effect estimate [mm/
year], 0.205; standard error, 0.132; P ¼ 0.121) after
adjustment for potential confounding. The most recently,
we3 combined adjusted data for growth rates from high-
quality observational comparative studies identiﬁed by
comprehensive search with those from the individual patient
data meta-analysis by the RESCAN collaborators.2 Pooled
analysis of 13 studies (our identifying 7 studies plus the 6
studies included in the meta-analysis by the RESCAN
collaborators2) demonstrated a statistically signiﬁcant
0.63 mm/year reduction in AAA growth rates with statin
therapy in the random-effects model (95% conﬁdence
interval [CI],0.98 to0.29 mm/year; P for effect¼ 0.0003;
P for heterogeneity < 0.0001). Signiﬁcant statistical
between-study heterogeneity of the study-speciﬁc estimates
may be due to the result by Karrowni et al.4 demonstrating
a probably excess beneﬁt of statin therapy (mean difference
[MD] of growth rates, 3.40 mm/year; 95% CI, 4.63
to 2.17 mm/year). Even though the result by Karrowni
et al.4 was eliminated in sensitivity analyses excluding indi-
vidual studies one at a time, combining the remaining 12
studies (there was minimal between-study heterogeneity
[P ¼ 0.05]) generated an attenuated but still statistically
signiﬁcant result favoring statin therapy (random-effects
MD,e0.42mm/year; 95% CI,e0.66 to0.18mm/year; P for
effect ¼ 0.0007).3 Thus, the evidence of the beneﬁt of statin
therapy for AAA growth is likely compelling and robust.
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